Clinical trial
Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients…
NCT00447902 · Boehringer Ingelheim, Industry · Terminated
Key facts
| NCT number | NCT00447902 |
|---|---|
| Title | Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation |
| Official title | Safety and Antiviral Activity of TPV in Hepatitis C or Hepatitis B HIV Coinfected Patients - TDM Randomised Pilot Evaluation |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | tipranavir, ritonavir |
| Enrollment | 11 |
| Start date | Mar 1, 2007 |
| Primary completion | Oct 1, 2008 |
| First posted | Mar 15, 2007 |
| Last update posted | May 14, 2014 |
| Countries | Argentina, Brazil, France, Germany, Italy, Spain, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: